Denis Cayet
The organizer
VARIANT CEO and patient-entrepreneur, Denis was diagnosed with an IRD. After a successful career in the international private postal sector, he founded the Stargardt Foundation and co-founded HORAMA / COAVE Therapeutics, pioneering gene therapy in ophthalmology.
Our scientific team
Jérôme Roger
PHD
Managing Partner & Scientific Officer, Centre d'Etude et de Recherche Thérapeutique en Ophtalmologie (CERTO) Retina; Pioneer of the CRX overexpression strategy.
Thomas Lamonerie
PHD
Scientific Officer, expert and professor in molecular biology, pioneer of the inhibition strategy, and Unit Director at the Valrose Institute of Biology (IBV) in Nice.
Jean Michel Rozet
PHD
Doctor in Genetics and INSERM Research Director, Group Leader at Institut Imagine. His lab there focusses on understanding the underlying mechanisms of rare diseases and improving the diagnostic techniques for earlier detection and outcome predictions.
Our clinical team
Francesca Simonelli
MD, PHD
Chief, Eye Clinic, School of Medicine, University of Campania Luigi Vanvitelli (UCLV), Naples, Italy. Leads one of Italy’s most renowned reference centers for rare ophthalmic diseases at Azienda Ospedaliera Universitaria Federico II
Anne Douar
PHD
Consultant for the development of innovative biologics (ATMPs) with a focus on RNA, Cell & Gene (nucleic acid based-) therapy medicinal products.
Anne Galy
PHD
Consultant, Rosebiology; Expert in CMC, preclinical and clinical development of ophthalmic gene therapy products.
Estelle Ferries
Regulatory affairs
Regulatory affairs expert, Raising Gene Consulting. Advises regulatory agencies and multiple clients in the field of gene therapy